Oncolytics Biotech holds annual shareholder meeting
ONCY•Oncolytics Biotech shareholders elected seven directors and ratified an independent registered public accounting firm for the year ending December 31, 2026, at the November 19 annual meeting.
1. Meeting results
Shareholders elected seven directors at Oncolytics Biotech’s annual meeting on November 19, 2026. They also ratified the appointment of an independent registered public accounting firm for the year ending December 31, 2026.




